Wedgewood Appoints Stanley Howell as Chief Operations Officer

Wedgewood Appoints Stanley Howell as Chief Operations Officer to Drive Growth and Operational Excellence

Press Release – February 06, 2025 – SWEDESBORO, N.J. – Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has appointed Stanley Howell as Chief Operations Officer. Howell brings extensive expertise in operations, strategy, and supply chain excellence, reinforcing Wedgewood’s commitment to innovation, efficiency, and best-in-class service for veterinary professionals. Howell’s appointment comes at a pivotal time as Wedgewood builds upon the momentum from VMX … Continue reading Wedgewood Appoints Stanley Howell as Chief Operations Officer to Drive Growth and Operational Excellence

AstraZeneca

AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery

Press Release – 23 January 2025 700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies AstraZeneca, a global pharmaceutical company focused on developing life changing medicines, today announced a C$820 million (US$570m) investment in Canada, creating more than 700 high-skilled jobs, across all areas of the business. The investment will support … Continue reading AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery

sanofi

Opella reaches study milestone for Cialis

Press Release – Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis (tadalafil) from a prescription to an over-the-counter medicine. This decision allows for the initiation of the AUT and makes Cialis the first PDE-5 inhibitor to achieve … Continue reading Opella reaches study milestone for Cialis

servier

Servier appoints David K. Lee to Executive Committee

Press Release – 13 January 2025 – Suresnes (France), January 13th, 2025 – Servier, an independent international pharmaceutical group, announces the appointment of David K. Lee to its Executive Committee as Executive Vice President for the United States, effective January 1, 2025. David K. Lee has held the position of Chief Executive Officer (CEO) of Servier Pharmaceuticals in the United States since the creation of … Continue reading Servier appoints David K. Lee to Executive Committee

hovione

Hovione strengthens its global position as a top employer for the third consecutive year

Hovione has once again solidified its position as a top employer. Press Release – Jan 16, 2025 Lisbon, January 16, 2025 – Hovione, an international integrated pharmaceutical development and manufacturing organization, has once again solidified its position as a top employer. For the third consecutive year, all four of its manufacturing sites – Lisbon (Portugal), Cork (Ireland), East Windsor (NJ, USA), and Macau – have been … Continue reading Hovione strengthens its global position as a top employer for the third consecutive year